Novo Nordisk Walks Away from $10 Billion Biotech Deal — Genius Move or Risky Gamble?
Novo Nordisk Shocks the Market Novo Nordisk, the Danish pharmaceutical giant, stunned investors by pulling out of a $10 billion
Novartis CEO Signals Bold M&A Plans Following $12 Billion Avidity Biosciences Deal
Novartis is making waves in the pharmaceutical industry with its latest move to acquire Avidity Biosciences for approximately $12 billion,